The Journal of Urology
Volume 184, Issue 3 , Pages 925-929 , September 2010

Lifelong Yearly Prostate Specific Antigen Surveillance is Not Necessary for Low Risk Prostate Cancer Treated With Radical Prostatectomy

  • Matthew K. Tollefson

      Affiliations

    • Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota
    • Corresponding Author InformationCorrespondence: Department of Urology, Mayo Clinic, 200 First St. SW, Rochester, Minnesota 55905 (telephone: 507-266-6011; FAX: 507-284-4951)
    • ,
  • Michael L. Blute

      Affiliations

    • Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota
    • ,
  • Laureano J. Rangel

      Affiliations

    • Department of Health Sciences Research, Mayo Medical School and Mayo Clinic, Rochester, Minnesota
    • ,
  • R. Jeffrey Karnes

      Affiliations

    • Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota
    • ,
  • Igor Frank

      Affiliations

    • Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota
    • Requests for reprints: Department of Urology, Mayo Clinic, 200 First St. SW, Rochester, Minnesota 55905 (telephone: 507-266-6091; FAX: 507-284-4951).

Received 27 January 2010

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225
  2. Harlan LC, Potosky A, Gilliland FD, et al. Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J Natl Cancer Inst. 2001;93:1864
  3. Horner MJ, Ries LAG, Krapcho M et al: SEER Cancer Statistics Review, 1975–2006. Bethesda: National Cancer Institute. Based on November 2008 SEER data submission posted to the SEER web site 2009. Available at http://seer.cancer.gov/csr/1975_2006/.
  4. Blute ML, Bergstralh EJ, Iocca A, et al. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. J Urol. 2001;165:119
  5. Graefen M, Karakiewicz PI, Cagiannos I, et al. Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer. J Clin Oncol. 2002;20:951
  6. Graefen M, Karakiewicz PI, Cagiannos I, et al. International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. J Clin Oncol. 2002;20:3206
  7. Greene KL, Meng MV, Elkin EP, et al. Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE). J Urol. 2004;171:2255
  8. Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol. 1999;17:1499
  9. Stephenson AJ, Scardino PT, Eastham JA, et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol. 2005;23:7005
  10. Dale W, Hemmerich J, Bylow K, et al. Patient anxiety about prostate cancer independently predicts early initiation of androgen deprivation therapy for biochemical cancer recurrence in older men: a prospective cohort study. J Clin Oncol. 2009;27:1557
  11. Chism K, Kunkel EJ. Prostate cancer: issues in psychosomatic medicine. Curr Psychiatry Rep. 2009;11:205
  12. Myers RP. The surgical management of prostate cancer: radical retropubic and radical perineal prostatectomy. In:  Lepor H editors. Prostatic Diseases. Philadelphia: W.B. Saunders Co; 1999;chapt 33
  13. Boorjian SA, Karnes RJ, Crispen PL, et al. The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy. J Urol. 2009;181:95
  14. Woloshin S, Schwartz LM, Welch HG. The risk of death by age, sex, and smoking status in the United States: putting health risks in context. J Natl Cancer Inst. 2008;100:845
  15. Pound CR, Partin AW, Eisenberger MA, et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 1999;281:1591
  16. Ward JF, Blute ML, Slezak J, et al. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy. J Urol. 2003;170:1872
  17. Sebo TJ, Cheville JC, Riehle DL, et al. Perineural invasion and MIB-1 positivity in addition to Gleason score are significant preoperative predictors of progression after radical retropubic prostatectomy for prostate cancer. Am J Surg Pathol. 2002;26:431
  18. Hoffmann NE, Sheinin Y, Lohse CM, et al. External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma. Cancer. 2008;112:1471
  19. Chavin G, Sheinin Y, Crispen PL, et al. Expression of immunosuppressive B7-H3 ligand by hormone-treated prostate cancer tumors and metastases. Clin Cancer Res. 2009;15:2174
  20. Epstein JI, Walsh PC, Carmichael M, et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA. 1994;271:368
  21. Kattan MW, Eastham JA, Wheeler TM, et al. Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. J Urol. 2003;170:1792
  22. Bastian PJ, Mangold LA, Epstein JI, et al. Characteristics of insignificant clinical T1c prostate tumors (A contemporary analysis). Cancer. 2004;101:2001
  23. Chun FK, Haese A, Ahyai SA, et al. Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men. Cancer. 2008;113:701
  24. Amling CL, Blute ML, Bergstralh EJ, et al. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. J Urol. 2000;164:101
  25. Tollefson MK, Slezak JM, Leibovich BC, et al. Stratification of patient risk based on prostate-specific antigen doubling time after radical retropubic prostatectomy. Mayo Clin Proc. 2007;82:422

 Study received institutional review board approval.

 For another article on a related topic see page 1211.

PII: S0022-5347(10)03562-7

doi: 10.1016/j.juro.2010.05.043

The Journal of Urology
Volume 184, Issue 3 , Pages 925-929 , September 2010

Article Tools

* Image Usage & Resolution